Exopharm Ltd (EX1)
EX1 Chart
EX1's Principal Activity is the investment in biopharmaceutical drug development.
Share Price Activity
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2021 YTD | |
| 1 Year | |
| vs Sector (1yr) | +481.98% |
| vs ASX 200 (1yr) | +444.59% |
Size
| Market Capitalisation | |
| ASX Rank | 872 of 2,237 |
| Sector Rank | 77 of 177 |
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Company Overview
Exopharm Limited (EX1) is a clinical-stage Australian exosome medicine company developing naive exosome products for regenerative medicine and engineered exosomes for new precision medicines. Exopharm owns a purification technology called Ligand-based Exosome Affinity Purification (LEAP).
Incorporation Details
No incorporation details available.
Corporate Details
| Head Office | Melbourne VIC 3000 |
| Website | www.exopharm.com |
| Registry | Automic Group |
| Auditor | William Buck Audit (VIC) Pty Ltd |
| Date Listed | 18 Dec 2018 |
Upcoming Calendar
No calendar entries available.
Dividend History
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors & Management
Director Transactions
EX1 directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of EX1 directors.
Shareholder Info
Top 20 Shareholders About the Data
Data supplied by Morningstar and accurate on Aug 24, 2020.
It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.
All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).
Shareholder Distribution
As reported in the most recent Annual Report.
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001+ | Total |
|---|---|---|---|---|---|---|
| No. of Shareholders | 31 | 184 | 173 | 561 | 156 | 1,105 |
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Altnia Holdings Pty Ltd | 30/06/2020 | 27,935,294 | 29.33 |
| Ian E Dixon | 09/11/2020 | 27,975,294 | 20.09 |
| Carl Charalambous | 27/01/2021 | 8,653,912 | 6.21 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 27-01-21 | Carl Charalambous | 1,400,084 | 5.20 | 6.21 |
| 21-12-20 | Carl Charalambous | 7,253,828 | -- | 5.20 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2020 | $0.25 | 30 June |
| 2019 | $0.41 | 28 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.